ArticleNeuro-oncology2008

Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase 1 trial in adults with malignant glioma.

David A Reardon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.